Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 19,281Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Dymista

02 1Flixotide

03 1Flixotide /Flovent

04 8Flixotide/Flovent

PharmaCompass

01

Brand Name : Flixotide/Flovent

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Flixotide/Flovent

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 581

2019 Revenue in Millions : 872

Growth (%) : -33

blank

02

Brand Name : Flixotide/Flovent

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Flixotide/Flovent

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 601

2020 Revenue in Millions : 574

Growth (%) : 6

blank

03

Brand Name : Flixotide/Flovent

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Flixotide/Flovent

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2022 Revenue in Millions : 672

2021 Revenue in Millions : 601

Growth (%) : 12

blank

04

Brand Name : Dymista

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Dymista

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 180

2021 Revenue in Millions : 168

Growth (%) : 7

blank

05

Brand Name : Flixotide/Flovent

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Flixotide/Flovent

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2023 Revenue in Millions : 487

2022 Revenue in Millions : 672

Growth (%) : -17

blank

06

Brand Name : Dymista

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Dymista

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 200

2022 Revenue in Millions : 180

Growth (%) : 11

blank

07

Brand Name : Flixotide /Flovent

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Flixotide /Flovent

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2015 Revenue in Millions : 997

2014 Revenue in Millions : 885

Growth (%) : -11%

blank

08

Brand Name : Flixotide

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Flixotide

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2014 Revenue in Millions : -11.80%

2013 Revenue in Millions :

Growth (%) :

blank

09

Brand Name : Flixotide/Flovent

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Flixotide/Flovent

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2016 Revenue in Millions : 790

2015 Revenue in Millions : 773

Growth (%) : 2

blank

10

Brand Name : Flixotide/Flovent

Fluticasone Propionate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Flixotide/Flovent

arrow
Antibody Engineering
Not Confirmed

Fluticasone Propionate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2017 Revenue in Millions : 840

2016 Revenue in Millions : 898

Growth (%) : -6

blank